abstract |
The invention relates to pharmaceutical agents containing at least one fluoroalkylated metal complex, with a critical micelle formation concentration of <10-<SUP>3</SUP> mol/l and a hydrodynamic micelle diameter of (2 Rh) > 1nm and at least one natural or synthetic Epothilone or Epothilone derivative, optionally with conventional galenic adjuncts. |